CliffBio
small molecule

LYBREL

ETHINYL ESTRADIOL; LEVONORGESTREL

Loss of exclusivity—loss of exclusivity
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand nameLYBREL
Active ingredientETHINYL ESTRADIOL; LEVONORGESTREL
Strength0.02MG;0.09MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2007
Marketing statusDISCN

More from Wyeth

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.